These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The Austrian Immunoglobulin in MS (AIMS) study: final analysis. Strasser-Fuchs S; Fazekas F; Deisenhammer F; Nahler G; Mamoli B Mult Scler; 2000 Oct; 6 Suppl 2():S9-13. PubMed ID: 11188778 [TBL] [Abstract][Full Text] [Related]
25. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. Achiron A; Kishner I; Dolev M; Stern Y; Dulitzky M; Schiff E; Achiron R J Neurol; 2004 Sep; 251(9):1133-7. PubMed ID: 15372259 [TBL] [Abstract][Full Text] [Related]
26. Intravenous immunoglobulin G therapy: effects of acute and chronic treatment in multiple sclerosis. Sørensen PS Mult Scler; 1996 Jul; 1(6):349-52. PubMed ID: 9345416 [TBL] [Abstract][Full Text] [Related]
27. Intravenous Immunoglobulins in MS. Stangel M; Gold R Int MS J; 2005 Apr; 12(1):5-10, 4. PubMed ID: 15955273 [TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, placebo-controlled trial: intravenous immunoglobulin treatment in patients with diffuse cutaneous systemic sclerosis. Takehara K; Ihn H; Sato S Clin Exp Rheumatol; 2013; 31(2 Suppl 76):151-6. PubMed ID: 23910617 [TBL] [Abstract][Full Text] [Related]
29. A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS. Visser LH; Beekman R; Tijssen CC; Uitdehaag BM; Lee ML; Movig KL; Lenderink AW Mult Scler; 2004 Feb; 10(1):89-91. PubMed ID: 14760960 [TBL] [Abstract][Full Text] [Related]
30. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. Léger JM; Chassande B; Musset L; Meininger V; Bouche P; Baumann N Brain; 2001 Jan; 124(Pt 1):145-53. PubMed ID: 11133794 [TBL] [Abstract][Full Text] [Related]
31. Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: a meta-analysis. Sorensen PS; Fazekas F; Lee M Eur J Neurol; 2002 Nov; 9(6):557-63. PubMed ID: 12453069 [TBL] [Abstract][Full Text] [Related]
32. An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris. Arnold DF; Burton J; Shine B; Wojnarowska F; Misbah SA Br J Dermatol; 2009 May; 160(5):1098-102. PubMed ID: 19222460 [TBL] [Abstract][Full Text] [Related]
33. Treatment of chronic progressive multiple sclerosis with intravenous immunoglobulins--interim results on drug safety of an ongoing study. IVIG study group. Poehlau D Mult Scler; 2000 Oct; 6 Suppl 2():S21-3. PubMed ID: 11188774 [TBL] [Abstract][Full Text] [Related]